Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Scope of Consolidation (Tables)

v3.25.0.1
Scope of Consolidation (Tables)
12 Months Ended
Dec. 31, 2024
Disclosure of Significant Investments in Subsidiaries and Associates [Abstract]  
Schedule of list of companies directly or indirectly controlled

The consolidated financial statements of the Group include the following companies controlled by the parent company Stevanato Group S.p.A. directly or indirectly through the subsidiaries Stevanato Group International a.s., Balda Medical GmbH and Spami S.r.l.:

 

 

 

 

 

 

 

 

% equity interest

Name

 

Segment

 

Description

 

Country of incorporation

 

2024

 

 

2023

Nuova Ompi S.r.l.

 

Biopharmaceutical and Diagnostic Solutions

 

Production of drug containment solutions and development of integrated solutions for the pharmaceutical industry

 

Italy

 

100%

 

 

100%

Spami S.r.l.

 

Engineering

 

Production plant and machinery

 

Italy

 

100%

 

 

100%

Stevanato Group International a.s.

 

Holding

 

Service/ Subholding company

 

Slovakia

 

100%

 

 

100%

Medical Glass a.s.

 

Biopharmaceutical and Diagnostic Solutions

 

Production of drug containment solutions

 

Slovakia

 

99.74%

 

 

99.74%

Stevanato Group N.A. S. de RL de CV (*)

 

Biopharmaceutical and Diagnostic Solutions

 

Service company

 

Mexico

 

 

 

 

100%

Ompi N.A. S. de RL de CV

 

Biopharmaceutical and Diagnostic Solutions

 

Production of drug containment solutions

 

Mexico

 

100%

 

 

100%

Ompi of America inc.

 

Biopharmaceutical and Diagnostic Solutions

 

Production and sale of drug containment solutions and analytical services

 

USA

 

100%

 

 

100%

Ompi do Brasil I. e C. de Em. Far. Ltda

 

Biopharmaceutical and Diagnostic Solutions

 

Production of drug containment solutions

 

Brazil

 

100%

 

 

100%

Perugini S.r.l.

 

Engineering

 

Production of consumables and mechanical components for industrial machines

 

Italy

 

100%

 

 

100%

Ompi Pharm. Packing Techn. Co. Ltd

 

Biopharmaceutical and Diagnostic Solutions

 

Production of drug containment solutions

 

China

 

100%

 

 

100%

Stevanato Group Denmark A/S

 

Engineering

 

Production plant and machinery

 

Denmark

 

100%

 

 

100%

Medirio SA

 

Biopharmaceutical and Diagnostic Solutions

 

Research and development

 

Switzerland

 

100%

 

 

100%

Balda Medical Gmbh

 

Biopharmaceutical and Diagnostic Solutions

 

Production of in-vitro diagnostic solutions

 

Germany

 

100%

 

 

100%

Balda C. Brewer Inc.

 

Biopharmaceutical and Diagnostic Solutions

 

Production of in-vitro diagnostic solutions

 

USA

 

100%

 

 

100%

Balda Precision Inc.

 

Biopharmaceutical and Diagnostic Solutions

 

Production metal components

 

USA

 

100%

 

 

100%

Ompi of Japan Co., Ltd.

 

Biopharmaceutical and Diagnostic Solutions

 

Sale of drug containment solutions

 

Japan

 

100%

 

 

100%

 

 

(*) In the fourth quarter of 2024, the liquidation process of Stevanato Group N.A. S. de RL de CV was completed with the cancellation from the local business register.